BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24073892)

  • 1. Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer.
    Popovici V; Budinska E; Bosman FT; Tejpar S; Roth AD; Delorenzi M
    BMC Cancer; 2013 Sep; 13():439. PubMed ID: 24073892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials.
    Taieb J; Sinicrope FA; Pederson L; Lonardi S; Alberts SR; George TJ; Yothers G; Van Cutsem E; Saltz L; Ogino S; Kerr R; Yoshino T; Goldberg RM; André T; Laurent-Puig P; Shi Q
    Ann Oncol; 2023 Nov; 34(11):1025-1034. PubMed ID: 37619846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?
    Yokota T
    Anticancer Agents Med Chem; 2012 Feb; 12(2):163-71. PubMed ID: 22043994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF(V600E) efficient transformation and induction of microsatellite instability versus KRAS(G12V) induction of senescence markers in human colon cancer cells.
    Oikonomou E; Makrodouli E; Evagelidou M; Joyce T; Probert L; Pintzas A
    Neoplasia; 2009 Nov; 11(11):1116-31. PubMed ID: 19881948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demystifying BRAF Mutation Status in Colorectal Liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions.
    Margonis GA; Boerner T; Bachet JB; Buettner S; Moretto R; Andreatos N; Sartore-Bianchi A; Wang J; Kamphues C; Gagniere J; Lonardi S; Løes IM; Wagner D; Spallanzani A; Sasaki K; Burkhart R; Pietrantonio F; Pikoulis E; Pawlik TM; Truant S; Orlandi A; Pikouli A; Pella N; Beyer K; Poultsides G; Seeliger H; Aucejo FN; Kornprat P; Kaczirek K; Lønning PE; Kreis ME; Wolfgang CL; Weiss MJ; Cremolini C; Benoist S; D'Angelica M
    Ann Surg; 2023 Sep; 278(3):e540-e548. PubMed ID: 36453261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive roles of KRAS mutation in colorectal cancer.
    Arrington AK; Heinrich EL; Lee W; Duldulao M; Patel S; Sanchez J; Garcia-Aguilar J; Kim J
    Int J Mol Sci; 2012 Sep; 13(10):12153-68. PubMed ID: 23202889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the Interplay of KRAS, NRAS, BRAF, and Micro-Satellite Instability in Non-Metastatic Colon Cancer: A Systematic Review.
    Orlandi E; Giuffrida M; Trubini S; Luzietti E; Ambroggi M; Anselmi E; Capelli P; Romboli A
    Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a prognostic difference among stage I lung adenocarcinoma patients with different BRAF-mutation status?
    Ma SS; Wang RR; Peng Q; Liu Y; Qian JY; Li MJ; Li K; Huang ZY; Wu LL; Xie D
    Thorac Cancer; 2024 Mar; 15(9):715-721. PubMed ID: 38362771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional Overall Survival After Diagnosis of Non-Metastatic Colon Cancer: Impact of Laterality, MSI, and KRAS Status.
    Tran CG; Goffredo P; Mott SL; Suraju MO; Kohn JF; Mishra A; Vauthey JN; Hassan I
    Ann Surg Oncol; 2024 Jan; 31(1):142-151. PubMed ID: 37857983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial/Ethnic and Sex Differences in Somatic Cancer Gene Mutations among Patients with Early-Onset Colorectal Cancer.
    Holowatyj AN; Wen W; Gibbs T; Seagle HM; Keller SR; Edwards DRV; Washington MK; Eng C; Perea J; Zheng W; Guo X
    Cancer Discov; 2023 Mar; 13(3):570-579. PubMed ID: 36520636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAS Mutations Predict Recurrence-Free Survival and Recurrence Patterns in Colon Cancer: A Unicenter Study in Morocco.
    El Agy F; El Bardai S; Boukansa S; Bouguenouch L; Benbrahim Z; Mazaz K; Benjelloun EB; Ousadden A; Ouldim K; Ibrahimi SA; Chbani L
    Cancer Control; 2024; 31():10732748241229290. PubMed ID: 38270484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signature of microsatellite instability, KRAS and BRAF gene mutations in German patients with locally advanced rectal adenocarcinoma before and after neoadjuvant 5-FU radiochemotherapy.
    Demes M; Scheil-Bertram S; Bartsch H; Fisseler-Eckhoff A
    J Gastrointest Oncol; 2013 Jun; 4(2):182-92. PubMed ID: 23730514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the prognostic value of
    Eklund EA; Mourad A; Wiel C; Sayin SI; Fagman H; Hallqvist A; Sayin VI
    Front Oncol; 2024; 14():1396285. PubMed ID: 38884086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Pathologic Analysis of Digitized Images of Colorectal Carcinoma Improves Prediction of Recurrence-Free Survival.
    Pai RK; Banerjee I; Shivji S; Jain S; Hartman D; Buchanan DD; Jenkins MA; Schaeffer DF; Rosty C; Como J; Phipps AI; Newcomb PA; Burnett-Hartman AN; Le Marchand L; Samadder NJ; Patel B; Swallow C; Lindor NM; Gallinger SJ; Grant RC; Westerling-Bui T; Conner J; Cyr DP; Kirsch R; Pai RK
    Gastroenterology; 2022 Dec; 163(6):1531-1546.e8. PubMed ID: 35985511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of ensemble clustering and survival tree analysis for identifying prognostic clinicogenomic features in patients with colorectal cancer from the 100,000 Genomes Project.
    Wei Y; Papachristou N; Mueller S; ; Chang WH; Lai AG
    BMC Res Notes; 2021 Oct; 14(1):385. PubMed ID: 34600575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives.
    Mukherji R; Marshall JL; Seeber A
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32707813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive and prognostic factors in colorectal cancer: a personalized approach.
    Kulendran M; Stebbing JF; Marks CG; Rockall TA
    Cancers (Basel); 2011 Mar; 3(2):1622-38. PubMed ID: 24212777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.
    Di Narzo AF; Tejpar S; Rossi S; Yan P; Popovici V; Wirapati P; Budinska E; Xie T; Estrella H; Pavlicek A; Mao M; Martin E; Scott W; Bosman FT; Roth A; Delorenzi M
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25246611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.
    Ogino S; Liao X; Imamura Y; Yamauchi M; McCleary NJ; Ng K; Niedzwiecki D; Saltz LB; Mayer RJ; Whittom R; Hantel A; Benson AB; Mowat RB; Spiegelman D; Goldberg RM; Bertagnolli MM; Meyerhardt JA; Fuchs CS;
    J Natl Cancer Inst; 2013 Dec; 105(23):1789-98. PubMed ID: 24231454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.
    Imamura Y; Lochhead P; Yamauchi M; Kuchiba A; Qian ZR; Liao X; Nishihara R; Jung S; Wu K; Nosho K; Wang YE; Peng S; Bass AJ; Haigis KM; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
    Mol Cancer; 2014 May; 13():135. PubMed ID: 24885062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.